Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP546902.RAerMU7jwyDBy4XgNpzY3xwizWVud3_upj5gzW7MxA2uI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP546902.RAerMU7jwyDBy4XgNpzY3xwizWVud3_upj5gzW7MxA2uI130_assertion type Assertion NP546902.RAerMU7jwyDBy4XgNpzY3xwizWVud3_upj5gzW7MxA2uI130_head.
- NP546902.RAerMU7jwyDBy4XgNpzY3xwizWVud3_upj5gzW7MxA2uI130_assertion description "[Moreover, CSF levels of MBL appear to be lower in AD patients than in control subjects which may indicate a higher degree of MBL consumption connected with complement activation in the AD patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP546902.RAerMU7jwyDBy4XgNpzY3xwizWVud3_upj5gzW7MxA2uI130_provenance.
- NP546902.RAerMU7jwyDBy4XgNpzY3xwizWVud3_upj5gzW7MxA2uI130_assertion evidence source_evidence_literature NP546902.RAerMU7jwyDBy4XgNpzY3xwizWVud3_upj5gzW7MxA2uI130_provenance.
- NP546902.RAerMU7jwyDBy4XgNpzY3xwizWVud3_upj5gzW7MxA2uI130_assertion SIO_000772 9631454 NP546902.RAerMU7jwyDBy4XgNpzY3xwizWVud3_upj5gzW7MxA2uI130_provenance.
- NP546902.RAerMU7jwyDBy4XgNpzY3xwizWVud3_upj5gzW7MxA2uI130_assertion wasDerivedFrom befree-20150227 NP546902.RAerMU7jwyDBy4XgNpzY3xwizWVud3_upj5gzW7MxA2uI130_provenance.
- NP546902.RAerMU7jwyDBy4XgNpzY3xwizWVud3_upj5gzW7MxA2uI130_assertion wasGeneratedBy ECO_0000203 NP546902.RAerMU7jwyDBy4XgNpzY3xwizWVud3_upj5gzW7MxA2uI130_provenance.